INS and type 2 diabetes mellitus: While the common insulin sensitizing drug Metformin decreases gut bacterial TMA production and eventual serum TMAO levels in T2D model mice [111], iodomethylcholine and 3,3-dimethyl-1-butanol directly inhibit the microbiota TMA [78,112].